Role evidence
Usage summary
Strongest role: Mention Only
Inclusion-required count: 0
Treatment-assignment count: 0
Stratification count: 0
Exploratory Only Signal
BRCA1/2 mutation
breast cancer · Monoclonal Antibody
BRCA1/2 mutation is flagged as exploratory only signal because public trials show mention only evidence in 1 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: MSI-H
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04122625